Neuroendocrine neoplasia goes molecular — time for a change

Guido Rindi, Bertram Wiedenmann

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In a cohort of 100 patients with neuroendocrine cancer, the use of NETest enabled earlier prediction of tumour progression and resulted in a reduction in the frequency of follow-up procedures. These outcomes are exciting and promising, but limited in value by the heterogeneity of the study cohort and by suboptimal assay sensitivity and specificity.
Original languageEnglish
Pages (from-to)149-150
Number of pages2
JournalNATURE REVIEWS. CLINICAL ONCOLOGY
Volume16
DOIs
Publication statusPublished - 2019

Keywords

  • NEN

Fingerprint

Dive into the research topics of 'Neuroendocrine neoplasia goes molecular — time for a change'. Together they form a unique fingerprint.

Cite this